Current Oncology | New Section “Cell Therapy” Established

We are pleased to announce a new Section in Current Oncology (ISSN: 1718-7729), entitled “Cell Therapy”, to provide a specific venue for this research.

The Section will cover basic, translational, and clinical research on all aspects related to cell therapy and transplantation in the treatment of cancer. This includes:

• conventional hematopoietic cell transplantation and associated novel insights, innovations, and new enabling technologies that can improve patient outcomes;
• immune effector cell therapies to treat cancer, such as chimeric-antigen receptor T or NK cell therapy or tumor-infiltrating cell-based approaches;
• identifying, collecting, and manufacturing cell products will also be considered favorably, particularly if related to clinical cancer outcomes.

We are now recruiting Editorial Board members and reviewers for the Section. If you are an active researcher in the field and are passionate about cutting-edge research, please do not hesitate to get in touch (currentoncology@mdpi.com). The journal is publishing collections of papers known as Special Issues. Papers published in a Special Issue will be collected together on a dedicated page of the journal website. If you are interested in editing a Special Issue, please submit your proposal here: https://www.mdpi.com/journalproposal/sendproposalspecialissue/curroncol.